HSR-TIGETH. San Raffaele-Telethon Institute for Gene Therapy (Milan, Italy)
References in periodicals archive ?
In addition, GSK will co-develop with Fondazione Telethon and Fondazione San Raffaele, six further applications of ex vivo stem cell therapy, using a new gene transfer technology developed by HSR-TIGET scientists, with the potential to treat a range of rare disorders.